How were Zosano Pharma's earnings last quarter?

Zosano Pharma Co. (NASDAQ:ZSAN) released its earnings results on Friday, May, 13th. The biotechnology company reported ($1.76) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.75) by $0.01. Zosano Pharma had a negative net margin of 8,375.11% and a negative trailing twelve-month return on equity of 177.06%.

When did Zosano Pharma's stock split?

Zosano Pharma's stock reverse split before market open on Tuesday, April 12th 2022. The 1-35 reverse split was announced on Tuesday, April 12th 2022. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, April 12th 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

What other stocks do shareholders of Zosano Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Zosano Pharma investors own include Aeterna Zentaris (AEZS) , Pennsylvania Real Estate Investment Trust (PEI) , Bionano Genomics (BNGO) , Gran Tierra Energy (GTE) , CNBX Pharmaceuticals (CNBX) , Matinas BioPharma (MTNB) , ADMA Biologics (ADMA) , Novan (NOVN) , Hallador Energy (HNRG) and EnLink Midstream (ENLC) .

When did Zosano Pharma IPO?

Zosano Pharma (ZSAN) raised $47 million in an IPO on Tuesday, January 27th 2015. The company issued 4,300,000 shares at a price of $10.00-$12.00 per share. Ladenburg Thalmann and Roth Capital Partners served as the underwriters for the IPO.

NASDAQ:ZSAN

Zosano Pharma (ZSAN) Stock Price, News & Analysis

→ “Forget Tesla, this is Elon’s Next Big Thing” (From InvestorPlace) (Ad)

Free ZSAN Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $0.0002
▼
$0.0002
50-Day Range: $0.52
▼
$112.00
52-Week Range: $0.46
▼
$37.45

Volume: 5,685 shs
Average Volume: 425,375 shs
Market Capitalization: $980.40

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Zosano Pharma alerts:

Ad InvestorPlace

“Forget Tesla, this is Elon’s Next Big Thing”

According to Forbes, this breakthrough could define the future of AI. Most people don’t know about it… Because it was found 750 miles away from Silicon Valley.

Click here to see the details.

About Zosano Pharma Stock (NASDAQ:ZSAN)

Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California.

Ad InvestorPlace

“Forget Tesla, this is Elon’s Next Big Thing”

According to Forbes, this breakthrough could define the future of AI. Most people don’t know about it… Because it was found 750 miles away from Silicon Valley.

Click here to see the details.

ZSAN Stock News Headlines

April 12, 2024 | seekingalpha.com

HOOK HOOKIPA Pharma Inc.

May 18, 2023 | bizjournals.com

East Bay Business News

April 16, 2024 | InvestorPlace (Ad)

Forget Nvidia, buy this A.I. Stock Now

Forget Nvidia, Microsoft or Google. Our tech expert and venture capitalist Luke Lango believes this is Elon Musk’s favorite A.I. stock. Why? Because this company is supplying Elon Musk with a key piece of advanced tech for his new A.I. venture.

April 6, 2023 | forbes.com

Astellas Pharma

February 5, 2023 | finance.yahoo.com

Giiant Pharma Receives Financial Support From the US Crohn’s and Colitis Foundation

November 5, 2022 | ca.finance.yahoo.com

Zosano Pharma Corporation (ZSANQ)

October 12, 2022 | msn.com

Bankrupt Zosano Sells Its Drug Delivery Tech That Once Partnered With Pharma Giants

August 28, 2022 | marketwatch.com

Bankrupt Zosano Pharma Says Unsecured Creditors Will Recoup 28% of Claims

April 16, 2024 | InvestorPlace (Ad)

Forget Nvidia, buy this A.I. Stock Now

August 27, 2022 | bizjournals.com

East Bay migraine patch developer Zosano closes sale in bankruptcy court for $1 million

August 25, 2022 | investing.com

Zosano Pharma Corp (ZSANQ)

July 26, 2022 | bizjournals.com

East Bay company promised drug-coated microneedle patches. Now it could be sold in bankruptcy court for just $1M

July 26, 2022 | bizjournals.com

A Fremont company promised drug-coated microneedle patches. Now it could be sold in bankruptcy court for just $1M.

June 2, 2022 | marketwatch.com

Zosano Pharma Shares Slide to New Depths After Chapter 11 Filing >ZSAN

June 2, 2022 | msn.com

Why Zosano Pharma Shares Are Getting Hammered Today

June 2, 2022 | seekingalpha.com

Zosano Pharma files for Chapter 11 bankruptcy protection; shares plummet 46%

June 2, 2022 | marketwatch.com

Cash-Strapped Zosano Pharma Files for Chapter 11 Bankruptcy >ZSAN

June 2, 2022 | bizjournals.com

East Bay migraine patch developer files for bankruptcy

June 2, 2022 | finance.yahoo.com

Zosano Pharma Files Voluntary Petition for Relief Under Chapter 11

May 18, 2022 | apnews.com

Emergex Vaccines Announces the Successful Coating of its Novel CD8+ T cell Adaptive COVID-19 Vaccine onto Zosano Pharma’s Micro-Needle Patch

May 13, 2022 | investing.com

Zosano Pharma Reports Q1 Net Loss of $33.4M

May 13, 2022 | finance.yahoo.com

Zosano Pharma Reports First Quarter 2022 Financial Results

May 3, 2022 | finance.yahoo.com

Zosano Pharma Corporation (ZSAN) Outpaces Stock Market Gains: What You Should Know

April 29, 2022 | bizjournals.com

Migraine patch Zosano Pharma developer suspends program, cutting more jobs

April 29, 2022 | finance.yahoo.com

Migraine patch developer Zosano Pharma suspends program, cutting more jobs

April 29, 2022 | seekingalpha.com

Zosano Pharma suspends program for migraine treatment M207

April 29, 2022 | finance.yahoo.com

Zosano Pharma Provides Corporate Update

See More Headlines

Receive ZSAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zosano Pharma and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 5/13/2022
Today: 4/15/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Pharmaceutical Preparations
Sub-Industry: N/A
Current Symbol: NASDAQ:ZSAN
CUSIP: N/A
CIK: 1587221
Web: www.zosanopharma.com
Phone: (510) 745-1200
Fax: N/A
Employees: 40
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($14.5034)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-29,920,000.00
Net Margins: -8,375.11%
Pretax Margin: -8,375.11%
Return on Equity: -177.06%
Return on Assets: -119.14%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 1.61
Quick Ratio: 1.61

Sales & Book Value

Annual Sales: $790,000.00
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $9.74 per share
Price / Book: 0.00

Miscellaneous

Outstanding Shares: 4,902,000
Free Float: 4,784,000
Market Cap: $980.40
Optionable: Not Optionable
Beta: 3.30

Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

Mr. Steven Lo (Age 55)
Sr. VP of Operations, Pres, CEO & Director
Comp: $534.08k
Ms. Christine Matthews (Age 53)
Chief Financial Officer
Comp: $312.45k
Dr. Donald J. Kellerman (Age 67)
VP of Clinical Devel. & Medical Affairs
Comp: $376.17k
Ms. Lu Liu
VP of Technical Operations
Jeffrey L. Quillen
Sec.
Ms. Kristina Warga
VP & Corp. Controller

Key Competitors

View All Competitors

ZSAN Stock Analysis - Frequently Asked Questions

How were Zosano Pharma's earnings last quarter?: Zosano Pharma Co. (NASDAQ:ZSAN) released its earnings results on Friday, May, 13th. The biotechnology company reported ($1.76) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.75) by $0.01. Zosano Pharma had a negative net margin of 8,375.11% and a negative trailing twelve-month return on equity of 177.06%.
When did Zosano Pharma's stock split?: Zosano Pharma's stock reverse split before market open on Tuesday, April 12th 2022. The 1-35 reverse split was announced on Tuesday, April 12th 2022. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, April 12th 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.
What other stocks do shareholders of Zosano Pharma own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Zosano Pharma investors own include Aeterna Zentaris (AEZS), Pennsylvania Real Estate Investment Trust (PEI), Bionano Genomics (BNGO), Gran Tierra Energy (GTE), CNBX Pharmaceuticals (CNBX), Matinas BioPharma (MTNB), ADMA Biologics (ADMA), Novan (NOVN), Hallador Energy (HNRG) and EnLink Midstream (ENLC).
When did Zosano Pharma IPO?: Zosano Pharma (ZSAN) raised $47 million in an IPO on Tuesday, January 27th 2015. The company issued 4,300,000 shares at a price of $10.00-$12.00 per share. Ladenburg Thalmann and Roth Capital Partners served as the underwriters for the IPO.

This page (NASDAQ:ZSAN) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Zosano Pharma (ZSAN) Stock Price, News & Analysis

About Zosano Pharma Stock (NASDAQ:ZSAN)

ZSAN Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

ZSAN Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info